Director Deals - (TM17)

Mark Crawford, Executive Director, bought 20 shares in the company on the 12th April 2021 at a price of £7.65. The Director now holds 6,868...

Wed, 14/04/2021 - 15:09


Director Deals - (LGEN)

Nigel Wilson, Financial Director, exercised 287,560 shares in the company on the 12th April 2021 at a price of £0.00. The Director now holds 10,952,555...

Wed, 14/04/2021 - 15:01


Director Deals - (LGEN)

Nigel Wilson, Financial Director, exercised 171,349 shares in the company on the 12th April 2021 at a price of £0.00. The Director now holds 10,664,995...

Wed, 14/04/2021 - 15:01


Director Deals - (LGEN)

Nigel Wilson, Financial Director, sold post-exercise 215,689 shares in the company on the 12th April 2021 at a price of £2.96. The Director now holds...

Wed, 14/04/2021 - 15:01


Kooth full-year revenue ahead of expectations

Digital mental health platform provider, Kooth reported revenue for the financial year of £13 million, up 50.3% from 2019 (£8.7million) ahead of expectations.

More...

Wed, 14/04/2021 - 14:26


Eleco appoints chief product officer

AIM-listed construction software specialist, Eleco has announced the appointment of Fredrik Pantze as chief product officer on the group's leadership team.

Jonathan Hunter, Eleco's CEO,...

Wed, 14/04/2021 - 14:13


MJ Hudson enters ESG partnership with MUFG Investor Services

The asset servicing arm of the Mitsubishi UFJ Financial Group (MUFG), one of the world's largest banks, has selected MJ Hudson as its global partner...

Wed, 14/04/2021 - 13:53


RiverFort expecting 2020 profit boost

RiverFort Global Opportunities has said it is expecting its net profit for 2020 to be in excess of £1.3 million and net assets to exceed...

Wed, 14/04/2021 - 13:25


FTSE 100 struggles for gains at midday as Tesco drags

Leading UK stocks continued to struggle at lunchtime on Wednesday with the benchmark FTSE 100 failing to find any real momentum as Wall Street hit...

Wed, 14/04/2021 - 12:58


Futura Medical narrows annual losses on lower R&D spend

Pharmaceutical company Futura Medical reported narrower losses as research and development spend fell sharply.

For the year ended 31 December 2020, pre-tax losses narrowed...

Wed, 14/04/2021 - 10:10


Pages